Keystone Resort Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

This meeting took place in 2001



For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Angiogenesis and Chronic Diseases (X1)


Organizer(s) Denisa D. Wagner, Richard O. Hynes and Mary E. Gerritsen
April 24—29, 2001
Keystone Resort • Keystone, Colorado USA
Abstract Deadline: Dec 21, 2000
Late Abstract Deadline:
Scholarship Deadline:
Early Registration Deadline: Feb 24, 2001


Summary of Meeting:
Angiogenesis, the development of new blood vessels, plays crucial roles both in embryonic development and in various physiological or pathological processes. These include wound healing, arthritis, atherosclerosis, obesity, various forms of blindness and cancer. The realization that tumors need to establish a vascular supply in order to survive and grow has excited much interest in the possibility that inhibition of angiogenesis offers a general way in which to inhibit tumor growth. Similarly, disorders in retinal vascularization constitute the major causes of blindness and ways to control retinal angiogenesis offer attractive opportunities for therapy. Recent advances in our understanding of the basic cell biology underlying vasculogenesis and angiogenesis have presented many candidate targets, but it remains true that these complex processes are only poorly understood. The purpose of this meeting will be to bring together scientists studying the basic molecular and cellular processes with those concerned with applications to specific diseases. The meeting will cover the secreted factors, receptors, adhesion proteins and other molecular players, as well as the cellular functions involved in vascular development and the involvement of vascularization in chronic diseases. By holding the meeting in parallel with a symposium on atherosclerosis, it will be possible to bring together scientists and clinicians covering many fields of vascular biology relevant to a variety of chronic diseases.

View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


TUESDAY, APRIL 24

14:00—19:00
Registration

Shavano Foyer
18:15—19:15
Welcome

Shavano Foyer
19:15—19:30
Orientation

Crestone/Red Cloud
19:30—20:30
Keynote Address (Joint)
Meeting has ended...abstracts no longer viewable online.

Crestone/Red Cloud
C. Ronald Kahn, Joslin Diabetes Center and Harvard Medical School, USA
Dissecting the Pathogenesis of Complex Disorders Using Knockout Mice


WEDNESDAY, APRIL 25

07:00—08:00
Breakfast

Shavano
08:00—11:00
Apoptosis and Angiogenesis (Joint)
Meeting has ended...abstracts no longer viewable online.

Crestone/Red Cloud
* Elisabetta Dejana, Uppsala University, Sweden
The Role of Proteins at Intercellular Junctions in Vascular Development and Angiogenesis

Douglas R. Green, St. Jude Children's Research Hospital, USA
Stress and the Control of Apoptosis

David A. Cheresh, University of California, San Diego, USA
Src Kinase Regulation of VEGF Signaling and Vascular Permeability Following Cerebral Ischemia

Gary H. Gibbons, NHLBI, National Institutes of Health, USA
Angiogenesis and Chronic Diseases/Cellular and Molecular Events in the Pathogenesis of Atherosclerosis

09:20—09:40
Coffee Break

Shavano Foyer
11:00—13:00
Poster Setup

Torreys
16:00—18:00
POSTER SESSION 1: Apoptosis and Angiogenesis/Endothelial Function/Blood Vessel Organization

Torreys
17:00—18:00
Social Hour

Torreys
20:00—21:00
Coffee Available

Shavano Foyer
20:00—22:00
Endothelial Function/Blood Vessel Organization
Meeting has ended...abstracts no longer viewable online.

Red Cloud
* Mary Ellen Gerritsen, Exelixis Inc., USA
Gene Expression Profiling in Three in vitro Models of Angiogenesis

Brad St. Croix, Johns Hopkins School of Medicine, USA
Gene Expression Profiles in Tumor Endothelium

Michael J. Detmar, ETH - Z├╝rich, Switzerland
Tumor Angiogenesis, Lymphangiogenesis and Metastasis

Tailoi Chan-Ling, University of Sydney, Australia
Mural Cell Differentiation in the Retina: Role in Vessel Stabilisation

20:00—22:00
Oxidative Stress and Atherosclerosis
Meeting has ended...abstracts no longer viewable online.

Crestone
* Jay W. Heinecke, University of Washington School of Medicine, USA

Alan M. Fogelman, University of California, Los Angeles, USA
Overview of the Role of LDL Oxidation in Atherogenesis

Garret A. FitzGerald, University of Pennsylvania, USA
Eicosanoids and Isoeicosanoids in Atherosclerosis

Linda L. Demer, University of California, Los Angeles, USA
Oxidized Lipids and Arterial and Skeletal Calcification


THURSDAY, APRIL 26

07:00—08:00
Breakfast

Shavano
08:00—11:00
Cellular Trafficking (Joint). Session Sponsored by Novartis Institute for Biomedical Research, Novartis Pharmaceuticals Corporation.
Meeting has ended...abstracts no longer viewable online.

Crestone/Red Cloud
* Denisa D. Wagner, Harvard Medical School, USA

Jeffrey M. Isner, St. Elizabeth's Medical Center, USA
Recruitment of Endothelial Cell Precursors in Angiogenesis

Israel F. Charo, ChemoCentryx, Inc., USA
The Role of Monocytes in Atherosclerosis and the Immune Response: Insights from the CCR2 Knockout Mice

Thomas J. Schall, ChemoCentryx, Inc., USA
Interplay of Endogenous and Infectious Chemokine Systems in Angiogenesis and Atherogenesis

Shahin Rafii, Weill Cornell Medical College, USA
Mobilization of Marrow-Derived Hematopoietic and VEGFR2+ Vasculogenic Precursor Cells by Angiogenic Factors is Essential for Angiogenesis

09:20—09:40
Coffee Break

Shavano Foyer
11:00—13:00
Poster Setup

Torreys
16:00—18:00
POSTER SESSION 2: Cellular Trafficking/Platelets and Angiogenesis

Torreys
17:00—18:00
Social Hour

Torreys
20:00—21:00
Coffee Available

Shavano Foyer
20:00—22:00
Platelets, Signaling and Angiogenesis
Meeting has ended...abstracts no longer viewable online.

Red Cloud
Timothy T. Hla, Boston Children's Hospital/Harvard Medical School, USA
Role of Sphingosine 1-Phosphate/EDG-1 Signaling in Angiogenesis

* Peter F. Carmeliet, University of Leuven, VIB, Belgium
Molecular Analysis of Angiogenesis: Therapeutic Insights from Transgenic Studies

Elisabeth Tournier-Lasserve, INSERM, France
Mutations of Krit 1 and Cerebral Cavernous Angiomas

Sang Hoon Lee, ABL Bio, South Korea
Inhibition of Angiogenesis by Mouse Sprouty Protein

20:00—22:00
Immunological Mechanisms in Atherogenesis
Meeting has ended...abstracts no longer viewable online.

Crestone
* Joseph L. Witztum, University of California, San Diego, USA

Linda K. Curtiss, The Scripps Research Institute, USA
Contribution of T Cells and NK Cells to Atherogenesis

Gregg J. Silverman, New York University Langone Medical Center, USA
Atherogenesis, Innate Immunity and B Cell Clonal Responses

Margaret Forney Prescott, Novartis Pharmaceuticals Corporation, USA
Short Presentation: Regulation in Lymphocyte Trafficking Inhibits Progression of Aortic and Graft Atherosclerosis


FRIDAY, APRIL 27

07:00—08:00
Breakfast

Shavano
08:00—11:00
Angiogenesis and Vasculogenesis
Meeting has ended...abstracts no longer viewable online.

Red Cloud
* Richard O. Hynes, Massachusetts Institute of Technology, USA

Gavin O. Thurston, Regeneron Pharmaceuticals Inc., USA
Overexpression of VEGF or Angiopoietin-1 and Chronic Disease

Kari K. Alitalo, University of Helsinki, Finland
VEGF-C and VEGFR-3 in Tumor Angiogenesis, Lymphangiogenesis and Metastasis

Luisa Iruela-Arispe, University of California, Los Angeles, USA
Endogenous Inhibitors of Angiogenesis

Brant M. Weinstein, NICHD, National Institutes of Health, USA
Fish Tales- Studying Embryonic Blood Vessel Formation Using the Zebrafish

Felix D. Karim, Exelixis Inc., USA
Genetic Identification of Angiogenic Regulators

08:00—11:00
Cellular Events in Atherosclerosis I. Session Sponsored by Novartis Institute for Biomedical Research, Novartis Pharmaceuticals Corporation.
Meeting has ended...abstracts no longer viewable online.

Crestone
* Stephen G. Young, University of California, Los Angeles, USA
New Models for Mouse Atherosclerosis

Alan R. Tall, Columbia University, USA
Cellular Mechanisms of Reverse Cholesterol Transport

Judith A. Berliner, University of California, Los Angeles, USA
Regulation of Leukocyte Endothelial Interactions by Oxidized Phospholipids

Wulf Palinski, University of California, San Diego, USA
Fetal Origins of Atherosclerosis

09:20—09:40
Coffee Break

Shavano Foyer
11:00—13:00
Poster Setup

Torreys
16:00—18:00
POSTER SESSION 3: Angiogenesis and Vasculogenesis/Nuclear Receptors/Targets for Therapy/Angiogenesis in Disease

Torreys
17:00—18:00
Social Hour

Torreys
20:00—21:00
Coffee Available

Shavano Foyer
20:00—22:00
Nuclear Receptors (Joint)
Meeting has ended...abstracts no longer viewable online.

Crestone/Red Cloud
Christopher K. Glass, University of California, San Diego, USA
Regulation of Macrophage Gene Expression by PPARgamma

* Ronald M. Evans, HHMI/The Salk Institute, USA
Nuclear Receptors in Obesity, Diabetes and Cardiovascular Disease

Joyce J. Repa, University of Texas Southwestern Medical Center, USA
Regulation of Sterol Homeostasis by Nuclear Hormone Receptors


SATURDAY, APRIL 28

07:00—08:00
Breakfast

Shavano
08:00—11:00
Targets for Therapy
Meeting has ended...abstracts no longer viewable online.

Red Cloud
* Helen M. Blau, Stanford University, USA
VEGF-Gene Therapy

Rubin M. Tuder, University of Ciolorado Hospital - Anschutz, USA
Endothelial Cell Dysfunction in Pulmonary Hypertension: Lessons from Cancer

Napoleone Ferrara, University of California, San Diego, USA
VEGF and Chronic Diseases

Thomas P. Richardson, University of Michigan, USA
Sezuential Growth Factor Delivery Directs the Formatin of Mature Blood Vessels

Michael Simons, Yale University, USA
Angiogenesis in Ischemic Heart Disease

08:00—11:00
Macrophage Biology and Atherogenesis
Meeting has ended...abstracts no longer viewable online.

Crestone
* Margaret Forney Prescott, Novartis Pharmaceuticals Corporation, USA

Ira Tabas, Columbia University, USA
Cellular Death Pathways in Free Cholesterol-Loaded Macrophages

Peter Libby, Brigham and Women's Hospital, USA
Macrophage Biology and Plaque Stability

MacRae F. Linton, Vanderbilt University Medical Center, USA
Macrophage Functions Affecting Atherogenesis

Martha K. Cathcart, Cleveland Clinic Foundation, USA
Monocyte Oxidation of LDL Lipids: Regulation of Expression of 15-Lipoxygenase

09:20—09:40
Coffee Break

Shavano Foyer
16:00—17:00
Coffee Available

Shavano Foyer
16:30—18:30
Angiogenesis in Disease
Meeting has ended...abstracts no longer viewable online.

Red Cloud
* Eli Keshet, Hebrew University, Israel
VEGF in Vascular Expansion and Regression

Gregg L. Semenza, Johns Hopkins University School of Medicine, USA
Control of VEGF-Mediated Angiogenesis in Ischemic and Neoplastic Diseases by Hypoxia-Inducible Factor 1

Rinnat Porat, Hebrew University, Hadassah Medical School, Israel
Conditional Switching of V.E.G.F. in the Brain Modeling Perinatal Vascular Injury

Gabriele A.I. Bergers, University of Leuven, Belgium
Mechanisms and Therapeutic Intervention of Tumor Angiogenesis in a Transgenic Mouse Model of Pancreatic Beta Cell Carcinogenesis

16:30—18:30
Cellular Events in Atherogenesis II
Meeting has ended...abstracts no longer viewable online.

Crestone
* Monty Krieger, Massachusetts Institute of Technology, USA
Overview of the Structure and Function of the Scavenger Receptor Family

David L. Williams, Stony Brook University, USA
Mechanisms of Cholesterol Transport by Scavenger Receptor BI (SR-BI)

Helen H. Hobbs, University of Texas Southwestern Medical Center, USA
Genetics of Cholesterol Metabolism: New Insights from a Rare Recessive Mutation

19:00—20:00
Social Hour

Shavano Foyer
20:00—22:00
Banquet

Torreys/Shavano
21:00—00:00
Entertainment

Torreys/Shavano

SUNDAY, APRIL 29

 
Departure


*Session Chair †Invited, not yet responded.



We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676